Low paediatric thrombin generation is caused by an attenuation of prothrombin conversion

Summary

Thrombin generation (TG) is decreased in children. TG is determined by two underlying processes: the conversion of prothrombin to thrombin and the inactivation of thrombin. Therefore, lower TG capacity in children can either be caused by a reduction of prothrombin conversion, an increase of thrombin inactivation, or both. In 36 children and 8 adults, TG and the factors that determine thrombin inactivation (antithrombin, α₂ Macroglobulin (α₂M) and fibrinogen) were measured. Prothrombin conversion, thrombin inhibitor complex formation, and the overall thrombin decay capacity were determined. In silico modelling was performed to determine the contribution prothrombin conversion and thrombin inactivation to deviant paediatric TG. Both the amount of prothrombin converted and the maximal prothrombin conversion rate are significantly reduced in children as compared to adults. This is partly due to the prothrombin levels being lower and partly to a lower prothrombin conversion rate. The overall thrombin decay capacity is not significantly different in children, but α₂Macroglobulin plays a more important role than it does in adults. In silico experiments demonstrate that reduced prothrombin conversion and to a lesser extent elevated α2M levels provide an explanation for low TG in children. Young age has a dual effect on prothrombin conversion. Lower plasma prothrombin levels result in decreased prothrombin conversion but the rate of prothrombin conversion is also decreased, i. e. the development of prothrombinase is lower than in adults.

Keywords

Developmental haemostasis - haemostatic balance - prothrombin conversion - thrombin generation - thrombin inactivation

• References

• 1 Monagle P, Massicotte P. Developmental haemostasis: secondary haemostasis. Semin Fetal Neonatal Med 2011; 16: 294-300.
• 2 Attard C, van der Straaten T, Karlaftis V. et al. Developmental hemostasis: agespecific differences in the levels of hemostatic proteins. J Thromb Haemost 2013; 11: 1850-1854.
• 3 Andrew M, Vegh P, Johnston M. et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
• 4 Appel IM, Grimminck B, Geerts J. et al. Age dependency of coagulation parameters during childhood and puberty. J Thromb Haemost 2012; 10: 2254-2263.
• 5 Haidl H, Cimenti C, Leschnik B. et al. Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 2006; 95: 772-775.
• 6 Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev 2010; 24: 63-68.
• 7 Ignjatovic V, Mertyn E, Monagle P. The coagulation system in children: developmental and pathophysiological considerations. Semin Thromb Hemost 2011; 37: 723-729.
• 8 Ignjatovic V, Summerhayes R, Than J. et al. Therapeutic range for unfractionated heparin therapy: age-related differences in response in children. J Thromb Haemost 2006; 04: 2280-2282.
• 9 Ignjatovic V, Furmedge J, Newall F. et al. Age-related differences in heparin response. Thromb Res 2006; 118: 741-745.
• 10 Monagle P, Barnes C, Ignjatovic V. et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-372.
• 11 Newall F, Ignjatovic V, Summerhayes R. et al. In vivo age dependency of unfractionated heparin in infants and children. Thromb Res 2009; 123: 710-714.
• 12 Koestenberger M, Cvirn G, Rosenkranz A. et al. Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography. Hamostaseologie 2008; 28 (Suppl. 01) S61-66.
• 13 Hemker HC, Giesen P, AlDieri R. et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper-and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-253.
• 14 Deutschmann A, Schlagenhauf A, Leschnik B. et al. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation. J Ped Gastroenterol Nutr 2013; 56: 401-407.
• 15 Lejhancova-Tousovska K, Zapletal O, Vytiskova S. et al. Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin-Frankfurt-Munster (BFM) protocols. Blood Coagul Fibrinolysis 2012; 23: 144-154.
• 16 Koestenberger M, Cvirn G, Nagel B. et al. Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease. Thromb Res 2008; 122: 13-19.
• 17 Kremers RM, Peters TC, Wagenvoord RJ. et al. The balance of pro-and anticoagulant processes underlying thrombin generation. J Thromb Haemost 2015; 13: 437-447.
• 18 Rosing J, Tans G, Govers-Riemslag JW. et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283.
• 19 Church FC, Whinna HC. Rapid sulfopropyl-disk chromatographic purification of bovine and human thrombin. Anal Biochem 1986; 157: 77-83.
• 20 Thaler E, Schmer G. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods. Br J Haematol 1975; 31: 233-243.
• 21 Hendrix H, Lindhout T, Mertens K. et al. Activation of human prothrombin by stoichiometric levels of staphylocoagulase. J Biol Chem 1983; 258: 3637-3644.
• 22 Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-246.
• 23 Hemker HC, Kremers R. Data management in thrombin generation. Thromb Res 2013; 131: 3-11.
• 24 Kuhle S, Male C, Mitchell L. Developmental hemostasis: pro-and anticoagulant systems during childhood. Semin Thromb Hemost 2003; 29: 329-338.
• 25 Jaffray J, Young G. Developmental hemostasis: clinical implications from the fetus to the adolescent. Ped Clin North Am 2013; 60: 1407-1417.
• 26 Dielis AW, Castoldi E, Spronk HM. et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 06: 125-131.
• 27 Butenas S, van’t Veer C, Mann KG. “Normal” thrombin generation. Blood 1999; 94: 2169-2178.
• 28 Andrew M, Schmidt B. Use of heparin in newborn infants. Semin Thromb Hemost 1988; 14: 28-32.